February 10, 2026, 12:00 PM PT, 3:00 PM ET
This webinar will provide an overview of the on-site validation approach used by Rapid Micro Biosystems™ to demonstrate that the Growth Direct® Rapid Sterility System, is equivalent or non-inferior, to the compendial sterility test described in the Pharmacopeia.
This webinar will provide:
- An overview of the Growth Direct® Rapid Sterility System and how this compares to the compendial sterility test. The attendees will understand why the system was designed the way it was and how automation will benefit and simplify their workflow.
- The validation criteria required for an alternate qualitative method will be discussed during the webinar, along with case studies for rapid sterility methods and industry guidance.
- At the end of the webinar the attendees should have a good foundation on sterility testing, how automation can help their workflow and how alternate growth-based methods can be validated.
Who should attend:
- Microbiologists
- Quality Control Directors/Managers
- Pharmaceutical Manufacturers
- Biologics Manufacturers
- Cell and Gene Therapy manufacturers and QC
Offered Free by: Rapid Micro Biosystems | American Pharmaceutical Review
See All Resources from: Rapid Micro Biosystems | American Pharmaceutical Review
